Arteris 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Q3 2026 revenue was $25.8 million, up 48% year over year and above the top end of guidance.
- ACV plus royalties totaled $104 million, up 39% year over year, while trailing 12-month royalties reached a record $9.4 million, up 71% year over year.
- RPO totaled a record $135 million, of which slightly more than half is expected to be recognized as revenue during the 12 months beginning October 1st, 2026.
- Non-GAAP gross profit was $22.8 million, with an 89% non-GAAP gross margin; GAAP gross profit was $22.3 million, with an 87% GAAP gross margin.
- Non-GAAP operating expenses were $24 million, and non-GAAP operating loss was $1.2 million, an improvement of $2.3 million from the same quarter a year ago.
- GAAP operating expenses were $33.6 million and GAAP operating loss was $11.3 million; non-GAAP net loss was $1.1 million, or $0.02 per diluted share, and GAAP net loss was $11.2 million, or $0.23 per diluted share.
- Free cash flow was negative $2.1 million, primarily reflecting the timing of customer payments; Arteris ended the quarter with $120 million in cash, cash equivalents, and investments, and no financial debt.
- Arteris surpassed 1,000 customer-confirmed design starts and achieved record royalties and RPO backlog.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good afternoon, everyone, and welcome to the Arteris third quarter 2026 earnings call. Please note this call is being recorded and simultaneously webcast. All material contained in the webcast is the sole property and copyright of Arteris, with all rights reserved. For opening remarks and introductions, I will now turn the call over to Erica Mannion at Sapphire Investor Relations.
Please go ahead. Thank you and good afternoon.
With me today from Arteris are Charlie Janac, Chief Executive Officer, and Saurabh Sinha, Chief Financial Officer. Charlie will begin with a brief review of the business results for the third quarter ended September 30, 2026. Saurabh will review the financial results for the third quarter of 2026, followed by the company's outlook for the fourth quarter and the full year of 2026. We will then open the call for questions. Before we begin, I would like to remind listeners that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements are based on management's current expectations and assumptions and involve material risks and uncertainties that could cause actual results or events to differ materially from those anticipated, and you should not place undue reliance on forward-looking statements.
Additional information regarding these risks, uncertainties, and factors that could cause results to differ appear in the press release Arteris issued today and in the documents and reports filed by Arteris from time to time with the Securities and Exchange Commission. Please note, during this call, management will cite certain non-GAAP measures, including, among others, non-GAAP net loss, non-GAAP net loss per share, and free cash flow, which are not measures prepared in accordance with U.S. GAAP. The non-GAAP measures are presented as we believe that they provide investors with a means of evaluating and understanding how the company's management evaluates the company's operating performance. These non-GAAP measures should not be considered in isolation from, as substitutes for, or superior to financial measures prepared in accordance with U.S. GAAP. A reconciliation of these non-GAAP measures to the nearest GAAP measure can be found in the press release for the quarter ended September 30, 2026.
In addition, for a definition of certain of the key performance indicators used in this presentation, such as annual contract value and remaining performance obligations, please see the press release for the quarter ended September 30, 2026. These key performance indicators are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may differ from similarly titled metrics or measures used by other companies, securities analysts, or investors. Listeners who do not have a copy of the press release for the quarter ended September 30, 2026, may obtain a copy by visiting the Investor Relations section of the company's website.
In addition, management will be referring to the third quarter 2026 earnings presentation, which can be found in the Investor Relations section of the company's website under the Events and Presentations tab. Before I turn the call over to Charlie, I would like to mention that management will participate in the ROTH Technology Conference on November 18 in New York and the Northland's Growth Conference on December 16, which takes place virtually. Now, I will turn the call over to CEO Charlie Janac.
Thank you, Erica, and thanks to everyone for joining us on our call today. In the third quarter, we achieved another record annual contract value plus royalties of $104 million, representing a 39% year-on-year increase, and record revenue of $25.8 million, representing a 48% increase. Once again, we also achieved record royalties and RPO backlog. License activity in the quarter remains strong, supported by the continuing integration of data center edge and physical AI computing. We are seeing this across all market verticals, led by enterprise computing, followed by automotive, industrial, consumer electronics, communications, and aerospace and defense applications. A third of those wins in dollar terms were with top 30 global technology customers. Demonstrating strong market momentum, a growing number of customers are deploying multiple products from our four system IP product lines.
This multi-product adoption reflects the critical role our solutions play in managing rising semiconductor design complexity. During the quarter, Arteris surpassed 1,000 customer-confirmed design starts. Arteris is increasingly becoming a key partner in the rapidly evolving semiconductor market, spanning the world's largest established technology companies through the most innovative startups. By enabling the underlying high-performance, efficient, safe, and secure data movement in silicon devices, Arteris has been able to support innovation from the smartphone inflection to today's deployments in sophisticated and complex AI infrastructure silicon, intelligent edge devices, and physical AI. Surpassing 1,000 customer-confirmed design starts demonstrates continued customer confidence in our products and our customer success organization. AI infrastructure semiconductor design activity remained strong in Q3, with a growing demand for Arteris products that help enable the underlying data movement in chips and chiplets.
In the third quarter, our largest deal was with a top hyperscaler who expanded their existing use of Arteris technology to accelerate the creation and integration of chips and chiplets. In addition, two of the industry's top 10 semiconductor companies expanded their usage of our products to support their existing AI accelerators and data center compute needs, as well as the growing demands for architecture across XPUs for agentic workloads and other applications. Physical AI is another area where we continue to see growing demand for Arteris products. Building upon our proven technology in automotive and autonomous systems, customers are able to scale our solutions to drones, humanoid robotics, and adjacent applications.
In the third quarter, one of our largest deals came from a leading automotive OEM, which expanded the use of Arteris technology for successive generations of their in-house advanced chip designs, where performance, energy efficiency, safety, and security are crucial. Another highlight of the third quarter was our announcement of the expansion of our chiplet and multi-die solution. As silicon design sophistication continues to grow across applications, the required physical semiconductor area becomes quite large, creating design, manufacturing, and yield challenges. As a result, the development of chiplets and their integration into multi-die SoCs is accelerating. This, in turn, introduces the challenge of addressing die-to-die communication and data movement that previously occurred seamlessly within one chip, now having to cross physical boundaries while maintaining performance, efficiency, and predictable traffic behavior.
The expansion of our chiplet and multi-die solution addresses this challenge by extending data movement across die-to-die links, allowing multiple dies to operate as a unified architecture. The new FlexGen Multi-Die and Ncore Multi-Die products expand the Arteris solution to support chiplet architectures. These increasingly include solutions for agentic AI workflows, HPC, data center, cloud infrastructure, physical AI, and others. Together with Arteris Magillem IP integration automation and Cycuity hardware security assurance, our expanded portfolio provides semiconductor engineering teams with technologies spanning data movement, system integration, and cybersecurity for increasingly complex multi-die designs. These new products are a direct result of close collaboration with customers such as AMD and Socionext, and ecosystem partners including Cadence, Silitronics, Synopsys, UniVista, and others. Chiplets, multi-die systems, AI infrastructure, and physical AI also increasingly require semiconductor cybersecurity assurance.
The growing security threats posed by fast-evolving frontier AI models' identification and exploitation of vulnerabilities are driving new and growing cybersecurity standards compliance requirements. This results in growing interest and demand for our Cycuity semiconductor cybersecurity assurance products. During the third quarter, we announced the expansion of the third-party IP program as part of the Trusted and Assured Microelectronics program. This program, driven in close collaboration by BAE Systems and SiFive, aims to address the growing challenge of ensuring the security and trustworthiness of commercially sourced third-party silicon IP and cybersecurity assurance methodologies for semiconductors used in mission-critical systems enabled by Arteris products. Our customers continue to innovate in exciting high-growth areas, which require a combination of high performance, efficiency, safety, and security, backed by global customer support.
Arteris continues to be in an excellent position to support demand for advanced semiconductor technologies in the AI era, spanning infrastructure silicon, edge devices, and physical AI systems. Our focus remains on enabling customers to accelerate their innovation while reducing development risks to bring their next-generation products to market with Arteris technology at its core. Lastly, I will hand the call over to our new CFO. Saurabh Sinha brings more than 25 years of financial leadership experience at public and high-growth technology companies, and we're excited to have him on board. With that, I will turn it over to Saurabh to discuss our financial results in detail.
Thank you, Charlie. Good afternoon, everyone. Since joining Arteris in September, I have spent the past few weeks integrating with the team and diving deep into our operations. It is a privilege to step into the company at such a pivotal moment in its growth. I look forward to collaborating closely with the team to capture the significant opportunities ahead and drive long-term value for both customers and shareholders. As I review our Q3 2026 results, I will refer to both GAAP and non-GAAP financial measures. The earnings release posted on our website includes a reconciliation of the non-GAAP measures to their most directly comparable GAAP measures. I will also refer to the Q3 earnings presentation, which is available in the Investor Relations section of our website under Events and Presentations.
We delivered another quarter of solid financial results, and in Q3, we exceeded or met our guidance on revenue and other key KPIs. Turning to slide five. Q3 revenue was $25.8 million, up 48% from a year ago and exceeding the top end of our guidance range. At quarter end, ACV plus royalties totaled $104 million, up 39% year over year and also exceeding the top end of our guidance, setting another record. Trailing 12 months royalties were $9.4 million, up 71% year over year and also a record high. Remaining performance obligations, or RPO, which represents contracted future revenue, totaled $135 million at quarter end, another record for Arteris. We expect slightly more than half of this amount to be recognized as revenue during the 12 months beginning October 1, 2026. Non-GAAP gross profit was $22.8 million for a non-GAAP gross margin of 89%.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
9 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
